Ontology highlight
ABSTRACT: Objectives
Isoniazid preventive therapy (IPT), for people living with HIV (PLHIV) is the proven and recommended intervention to avert tuberculosis (TB). In 2015, Nepal implemented 6?months of IPT for all PLHIV registered for HIV care in antiretroviral therapy (ART) centres. After programmatic implementation, there has been no systematic assessment of IPT initiation and completion rates among PLHIV. We aimed to assess IPT initiation and completion rates in the Far-Western Region (FWR) of Nepal.Design
We conducted a retrospective cohort study using secondary data extracted from registers maintained at ART centres.Setting
All 11 ART centres in the FWR of Nepal.Participants
All PLHIV registered for care between January 2016 and December 2017 in 11 ART centres.Primary outcome measures
IPT initiation and completion rates were summarised as percentages with 95% CI. Independent association between patient characteristics and non-initiation of IPT was assessed using cluster-adjusted generalised linear model (log binomial regression) and adjusted relative risk (RR) with 95%?CI was calculated.Result
Of the 492 PLHIV included, 477 (97.0%) did not have active TB at registration. Among 477 without active TB, 141 (29.8%, 95%?CI 25.7% to 34.1%) had been initiated on IPT and 85 (17.8%) were initiated within 3?months of registration. Of 141 initiated on IPT, 133 (94.3%, 95%?CI 89.1% to 97.5%) had completed 6?months of IPT. Being more than 60 years of age (RR-1.3, 95%?CI 1.1 to 1.7), migrant worker (RR-1.3, 95%?CI 1.1 to 1.4) and not being initiated on ART (RR-1.4, 95%?CI 1.1 to 1.8) were significantly associated with IPT initiation.Conclusions
In FWR of Nepal, three out of 10 eligible PLHIV had received IPT. Among those who have received IPT, the completion rate was good. The HIV care programme needs to explore the potential reasons for this low coverage and take context specific corrective action to fix this gap.
SUBMITTER: Dhungana GP
PROVIDER: S-EPMC6549711 | biostudies-literature | 2019 May
REPOSITORIES: biostudies-literature
BMJ open 20190529 5
<h4>Objectives</h4>Isoniazid preventive therapy (IPT), for people living with HIV (PLHIV) is the proven and recommended intervention to avert tuberculosis (TB). In 2015, Nepal implemented 6 months of IPT for all PLHIV registered for HIV care in antiretroviral therapy (ART) centres. After programmatic implementation, there has been no systematic assessment of IPT initiation and completion rates among PLHIV. We aimed to assess IPT initiation and completion rates in the Far-Western Region (FWR) of ...[more]